Karl Nagler, Partner of the Gimv Health & Care platform, on this transaction: The technology platform that Topas Therapeutics has developed is within an emerging field that recently has gained increasing momentum with investors and pharma companies.
A clear, high-purity thermoplastic with a long, proven track record of successful medical applications, Topas COC is now filling the needs of many healthcare companies who seek a safe and readily available replacement for Barex materials.
The proceeds of the Series A funding are expected to allow Topas to expand and accelerate its proprietary liver-based tolerance induction platform and to progress with its own product development efforts in multiple autoimmune and inflammatory indications, including multiple sclerosis, into clinical proof-of-concept stage.
Now Topas has added an injection/injection blow/stretch blow material which is easier to work with, and has started blending COC with other polyolefins for medical, electrical/electronics, and high-performance film applications.
"We've developed a new solution for converters and packagers that eliminates typical tradeoffs and provides low-temperature shrinkage with high modulus," says Timothy Kneale, president of Topas Advanced Polymers.
The impact strength of Topas with Tg = 140[degrees]C is about 21 J/m (Notched Izod) (52.3 J/m = 1 ft-lb/in), which is adequate for many applications; however, there are certain applications where it is desirable to have an impact strength greater than 50 J/m while maintaining its high optical transparency.
All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.